Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
United States
City of Hope Medical center, Duarte, California University of Michigan, Ann Arbor, Michigan The Ohio State University Comprehensive Cancer Center, Columbus, Ohio